Cite

HARVARD Citation

    Rousseau, A. et al. (2023). Clinical outcomes by infusion timing of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer. European journal of cancer. pp. 107-114. [Online]. 
  
Back to record